Company: NDRA
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001654954-25-012254
Chunk: 61

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 61
---
 under the 2016 Plan in the future are not determinable at this time.

Equity Compensation Plan Table

The following table presents information on the Company’s equity compensation plans as of December 31, 2024. All outstanding awards relate to our common stock.

| Plan Category                                              |     | Number of Securities to Be Issued upon Exercise of Outstanding Options, Warrants and Rights(a) |        |     | Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights(b) |           |     | Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (Excluding Securities Reflected in Column (a))(c) |          |
|:-----------------------------------------------------------|:----|:-----------------------------------------------------------------------------------------------|-------:|:----|:-------------------------------------------------------------------------------|----------:|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------|---------:|
| Equity compensation plans approved by security holders     |     |                                                                                                | 278(1) |     | $                                                                              | 30,628.90 |     |                                                                                                                                                | 1,459(2) |
| Equity compensation plans not approved by security holders |     |                                                                                                |      - |     |                                                                                |         - |     |                                                                                                                                                |        - |
| Total                                                      |     |                                                                                                |    278 |     | $                                                                              | 30,628.90 |     |                                                                                                                                                |    1,459 |

_________________

| (1) | Consists of outstanding stock options exercisable for shares of common stock issued under the 2016 Plan.                                                                                                                              |
| (2) | As of January 1, 2025, as a result of an automatic increase to the pool of shares available for issuance under the 2016 Plan on such date, the number of shares available for future issuance under the 2016 Plan was 179,771 shares. |

Summary of U.S. Federal Income Tax Consequences

The following summary is intended only as a general guide to the U.S. federal income tax consequences of participation in the 2016 Plan. The summary is based on existing U.S. laws and regulations, and there can be no assurance that those laws and regulations will not change. The summary is not complete and does not discuss the tax consequences upon a participant’s death, or the income tax laws of any municipality, state or foreign country in which the participant may reside. Tax consequences for any particular participant may vary based on individual circumstances.

| 43 |

Incentive Stock Options

A participant recognizes no taxable income for